Sharing knowhow and joining forces towards Health for All

Fair medicines: Protection of clinical trial participants in countries outside the EU

Fair medicines: Protection of clinical trial participants in countries outside the EU

No less than fourteen members of the European Parliament took part in the lunchtime debate that Wemos organized in Strasbourg (on September 14) on the subject of unethical drug trials in developing countries. Such a large turnout is unique in the history of Wemos and clearly shows the effectiveness of our lobbying strategy. After the debate, Annelies den Boer from Wemos addressed the European Parliament’s Bioethics Committee. She is impressed by the European measures in the pipeline to combat unethical trials.

Wemos news release, 11 October 2011
Briefing paper by SOMO and Wemos wrote for Strasbourg
More information on Wemos’ work on medicines

Document Actions